Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary P Coffey

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Translational Neurodegeneration|December 6, 2017
Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer's disease subjects: an exploratory studyAndrea C Klaver, Mary P Coffey, David A Bennett, et al.
International Immunopharmacology|October 3, 2012
Effects of intravenous immunoglobulin on alpha synuclein aggregation and neurotoxicityLynnae M Smith, Andrea C Klaver, Mary P Coffey, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 4, 2015
CSF Nrf2 and HSPA8 in Parkinson's disease patients with and without LRRK2 gene mutationsDavid A Loeffler, Lynnae M Smith, Mary P Coffey, et al.
Frontiers in Aging Neuroscience|August 11, 2016
Age-Related Decrease in Heat Shock 70-kDa Protein 8 in Cerebrospinal Fluid Is Associated with Increased Oxidative StressDavid A Loeffler, Andrea C Klaver, Mary P Coffey, et al.
Journal of Neuroscience Methods|January 26, 2010
Measurement of anti-Abeta1-42 antibodies in intravenous immunoglobulin with indirect ELISA: the problem of nonspecific bindingAndrea C Klaver, Lynnae M Patrias, Mary P Coffey, et al.
Plos One|January 4, 2013
α-Synuclein and anti-α-synuclein antibodies in Parkinson's disease, atypical Parkinson syndromes, REM sleep behavior disorder, and healthy controlsLynnae M Smith, Mya C Schiess, Mary P Coffey, et al.
Frontiers in Aging Neuroscience|April 20, 2017
Increased Oxidative Stress Markers in Cerebrospinal Fluid from Healthy Subjects with Parkinson's Disease-Associated <i>LRRK2</i> Gene MutationsDavid A Loeffler, Andrea C Klaver, Mary P Coffey, et al.
The Journal of Pediatrics|February 23, 2016
Diagnosing Jaundice by Eye-Outpatient Assessment of Conjunctival Icterus in the NewbornM Jeffrey Maisels, Mary P Coffey, Brian Gendelman, et al.
Journal of Neuroinflammation|August 11, 2011
ELISA measurement of specific non-antigen-bound antibodies to Aβ1-42 monomer and soluble oligomers in sera from Alzheimer's disease, mild cognitively impaired, and noncognitively impaired subjectsAndrea C Klaver, Mary P Coffey, Lynnae M Smith, et al.
Advances in Urology|February 25, 2015
Predictors of incisional hernia after robotic assisted radical prostatectomyAvinash Chennamsetty, Jason Hafron, Luke Edwards, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Translational Neurodegeneration|December 6, 2017
Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer's disease subjects: an exploratory studyAndrea C Klaver, Mary P Coffey, David A Bennett, et al.
International Immunopharmacology|October 3, 2012
Effects of intravenous immunoglobulin on alpha synuclein aggregation and neurotoxicityLynnae M Smith, Andrea C Klaver, Mary P Coffey, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 4, 2015
CSF Nrf2 and HSPA8 in Parkinson's disease patients with and without LRRK2 gene mutationsDavid A Loeffler, Lynnae M Smith, Mary P Coffey, et al.
Frontiers in Aging Neuroscience|August 11, 2016
Age-Related Decrease in Heat Shock 70-kDa Protein 8 in Cerebrospinal Fluid Is Associated with Increased Oxidative StressDavid A Loeffler, Andrea C Klaver, Mary P Coffey, et al.
Journal of Neuroscience Methods|January 26, 2010
Measurement of anti-Abeta1-42 antibodies in intravenous immunoglobulin with indirect ELISA: the problem of nonspecific bindingAndrea C Klaver, Lynnae M Patrias, Mary P Coffey, et al.
Plos One|January 4, 2013
α-Synuclein and anti-α-synuclein antibodies in Parkinson's disease, atypical Parkinson syndromes, REM sleep behavior disorder, and healthy controlsLynnae M Smith, Mya C Schiess, Mary P Coffey, et al.
Frontiers in Aging Neuroscience|April 20, 2017
Increased Oxidative Stress Markers in Cerebrospinal Fluid from Healthy Subjects with Parkinson's Disease-Associated <i>LRRK2</i> Gene MutationsDavid A Loeffler, Andrea C Klaver, Mary P Coffey, et al.
The Journal of Pediatrics|February 23, 2016
Diagnosing Jaundice by Eye-Outpatient Assessment of Conjunctival Icterus in the NewbornM Jeffrey Maisels, Mary P Coffey, Brian Gendelman, et al.
Journal of Neuroinflammation|August 11, 2011
ELISA measurement of specific non-antigen-bound antibodies to Aβ1-42 monomer and soluble oligomers in sera from Alzheimer's disease, mild cognitively impaired, and noncognitively impaired subjectsAndrea C Klaver, Mary P Coffey, Lynnae M Smith, et al.
Advances in Urology|February 25, 2015
Predictors of incisional hernia after robotic assisted radical prostatectomyAvinash Chennamsetty, Jason Hafron, Luke Edwards, et al.
Pageof 3